Bio-Techne Corp
(TECH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,398 | 96,072 | 79,612 | 34,958 | 17,403 |
| Depreciation Amortization | 20,085 | 78,171 | 58,252 | 38,930 | 19,052 |
| Income taxes - deferred | -607 | -13,582 | -11,114 | -9,106 | -3,768 |
| Accounts receivable | -1,405 | -15,000 | -13,136 | 7,848 | 8,307 |
| Accounts payable and accrued liabilities | 1,456 | 6,101 | 7,977 | 5,385 | 3,107 |
| Other Working Capital | -12,968 | -27,751 | -26,280 | -10,072 | -9,958 |
| Other Operating Activity | 19,580 | 57,608 | 30,362 | 18,068 | 5,305 |
| Operating Cash Flow | $40,539 | $181,619 | $125,673 | $86,011 | $39,448 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,560 | -21,896 | -20,478 | -20,666 | -11,694 |
| PPE Investments | -10,525 | -25,411 | -13,719 | -8,794 | -4,190 |
| Net Acquisitions | N/A | -289,492 | -272,286 | -272,287 | -272,229 |
| Investing Cash Flow | $-15,085 | $-336,799 | $-306,483 | $-301,747 | $-288,113 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 580,000 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 580,000 | 580,000 | 580,000 |
| Debt Repayment | -19,125 | N/A | -396,375 | -373,250 | -357,125 |
| Common Stock Issued | 8,952 | 37,950 | 27,029 | 18,860 | 16,453 |
| Common Stock Repurchased | N/A | -15,405 | -15,405 | -15,404 | N/A |
| Dividend Paid | -12,169 | -48,364 | -36,237 | -24,151 | -12,066 |
| Other Financing Activity | -1,927 | -419,797 | -4,731 | -4,731 | -4,731 |
| Financing Cash Flow | $-24,269 | $134,384 | $154,281 | $181,324 | $222,531 |
| Exchange Rate Effect | -2,180 | -308 | 99 | -1,692 | -1,182 |
| Beginning Cash Position | 100,886 | 121,990 | 121,990 | 121,990 | 121,990 |
| End Cash Position | 99,891 | 100,886 | 95,561 | 85,886 | 94,674 |
| Net Cash Flow | $-995 | $-21,104 | $-26,429 | $-36,104 | $-27,316 |
| Free Cash Flow | |||||
| Operating Cash Flow | 40,539 | 181,619 | 125,673 | 86,011 | 39,448 |
| Capital Expenditure | -10,525 | -25,411 | -13,719 | -8,794 | -4,190 |
| Free Cash Flow | 30,014 | 156,208 | 111,954 | 77,217 | 35,258 |